Skip to content
Artwork for Heart Doc VIP with Dr. Joel Kahn
Health & FitnessAlternative Health

Heart Doc VIP with Dr. Joel Kahn

Dr. Joel Kahn

Join Dr. Joel Kahn, the internationally recognized heart doctor, as he brings his unique blend of Eastern and Western medicine to Heart Doc VIP, the podcast that empowers you to take charge of your health. With a focus on the wellness of mind, body, and spirit, Dr. Kahn delves into the latest research and interviews leading experts in the health and wellness space, including Health Heroes who share their inspiring journeys to wellness.

Each episode of Heart Doc VIP provides listeners with practical advice and tools to help them live their best lives. Dr. Kahn doesn't shy away from controversial topics and is not afraid to take on the giants and expose lies, follies, and confusion in the health industry. With his extensive knowledge and experience, he guides listeners through the maze of conflicting information to help them make informed decisions about their health.

So if you're ready to feel better, look better, and live better, join Dr. Joel Kahn on Heart Doc VIP, the podcast that's changing the way we think about health and wellness.

Play
  • 24 episodes
  • weekly
  • Avg 27 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • Tuesday · 29 min

    Episode 514: Blockbuster News About Lipoprotein(a) Therapy

    This week, Dr. Kahn discusses the widespread disappointment following Novartis' announcement that its 8,000-patient HORIZON trial of a lipoprotein(a)-lowering drug failed to meet its primary endpoint. The news came as a major surprise and disappointment to patients eagerly awaiting access to this medication. No additional details have been released, and there is not yet a published paper to review. Dr. Kahn discusses the possible reasons the trial failed and what he plans to do moving forward. Other topics include lifestyle factors associated with sudden cardiac arrest, mindfulness for elevated blood pressure, hormone therapy and the female brain during menopause, the risks of off-label testosterone therapy in men, GLP-1 medications and lifespan, Mounjaro and cardiovascular risk, TMAO and brain atrophy, statins and reduced dementia risk, and the connection between adverse pregnancy outcomes and future cardiovascular disease. Dr. Kahn's new book, Don't Drop Dead, is available in print, audiobook, and Kindle formats on Amazon. Finally, thanks to WellBean and its amazing bean bars. Use promo code DrKahn15 to save money on your order.

  • September 4 · 26 min

    Episode 513: The Emerging Science of Pomegranates and Urolithin A

    Dr. Kahn interviews Anurag Singh, MD, PhD, Chief Medical Officer of Timeline Nutrition, whose research has focused on urolithin A, a compound produced from nutrients found in pomegranates. Nearly 20 years of research have resulted in more than 500 studies, 25 human clinical trials, and 80 patents related to this unique compound, which is available in powders, capsules, and even gummies. Research suggests that urolithin A may safely support mitochondrial renewal and muscle strength. Timeline Nutrition was also selected as a finalist in the $101 million XPRIZE Healthspan competition. Listeners can use the discount code KAHN10 to save on orders from Timeline Nutrition.

  • September 1 · 27 min

    Episode 512: How Common Is Silent Atherosclerosis? More Common Than You Think

    This week, Dr. Kahn reviews several important studies presented at the European Society of Cardiology Congress. The REACT trial examined how often previously undetected atherosclerosis appears in the coronary, carotid, and femoral arteries. The results are startling and reinforce the importance of the #TestNotGuess approach to cardiovascular health. Dr. Kahn also discusses encouraging research showing how plant-based diets may reduce cardiovascular disease risk. Additional topics include: NT-proBNP testing for predicting future cardiovascular disease The connection between coronary calcium scores and dementia risk Hormone replacement therapy and dementia Dietary flavanols and Parkinson's disease Blood pressure medications that may help protect the brain Blood thinners for people with lower-risk atrial fibrillation Vitamin K2 and the progression of coronary calcification This episode is sponsored by delicious and healthy WellBean. Use discount code DrKahn15 at checkout.

  • August 25 · 27 min

    Episode 511: Vascular Disease at Age 23 (Protect Our Young)

    This week, Dr. Kahn returns to one of his passion topics: educating young people about healthy lifestyles beginning in middle school and high school, if not earlier, and setting them up for a healthy future. A new study finds that the risk of heart disease and actual changes in the arteries are both common by age 23. It's a tragic reality. Other topics include dry cleaning and Parkinson's disease, amino acids and prostate cancer risk, meal timing and longevity, cooking classes and healthy diets (PlantRN), statins at age 80, exercise and the reversal of artery disease, lipoprotein(a) and heart disease, and alcohol versus healthy lifestyles in relation to the risk of sudden cardiac death. Thanks to WellBean for sponsoring this episode. Use the discount code DrKahn15 on delicious and healthy food bars made with legumes. They're my favorite snack.

  • August 18 · 26 min

    Episode 510: The TG/HDL Ratio and Your Risk of Disease

    This week, Dr. Kahn discusses the triglyceride-to-HDL (TG/HDL) ratio and how this simple lab measurement can help predict insulin resistance, type 2 diabetes, liver disease, and heart disease. It is also a marker of visceral fat and an easy, readily available way to add valuable risk information to your health journey. Dr. Kahn also discusses how genetics can influence the TG/HDL ratio. Other topics include tomatoes for the liver, tirzepatide for the heart, lifestyle for the heart, junk food and prostate cancer, belly fat and the heart, alcohol and the heart, and the power of climbing stairs. Thanks to our sponsor, WellBean. Their delicious bean-based bars make it easy to add more plant-based nutrition to your day. Visit wellbean.life and use discount code DrKahn15 to save on your order.

  • August 11 · 25 min

    Episode 509: How to Upgrade Your Gene Activity in 4 Weeks

    This week, Dr. Kahn discusses new research showing that after just 4 weeks of eating a whole-food, plant-based diet, sophisticated measures of gene activity demonstrate a reversal in aging and a reduction in inflammation. In another study, the calorie advantage of a plant-based diet is discussed, with the equation H=N/C (Health = Nutrition/Calories) proving to be a useful reminder. Finally, athletic performance in college athletes eating plant-based or omnivore diets was equivalent, which is reassuring to many. Dr. Kahn and his wife will begin their 50th year of plant-based diets in September. Other topics include more conversation on advanced glycation end products, dietary protein, finerenone for the kidneys, the top 3 modifiable risk factors for dementia and heart attacks, red hair color and heart disease, Viagra and statins for the prevention of cancer metastases, and fatty liver disease. Thanks to our sponsor, WellBean, and the discount code DrKahn15 for sponsoring this week's episode.

  • August 4 · 30 min

    Episode 508: Why Cooking to Reduce AGE Content Is a Healthy Habit

    This week, Dr. Kahn discussed new research on advanced glycation end-products (AGEs) and cooking methods. High levels of AGEs promote many disease states and can be avoided with water-based cooking methods like steaming, boiling, and pressure cooking. Other topics include visceral fat loss and brain health, bitter hops extract for weight loss, the Planetary Health Diet, fructose in the diet and cancer growth, a failed study on inflammation, and the role of multivitamins in cardiac health. Thanks to the Fresh Pressed Olive Oil Club and the $1 offer at getfreshDrKahn.com.

  • July 28 · 22 min

    Episode 507: The Nuance of How Much Dietary Protein for Optimal Health

    This week, Dr. Kahn discusses new data from the amazing Valter Longo, PhD, and his colleagues regarding optimizing diet for both longevity and strong muscles. In a new publication, Dr. Longo used mouse models to show that animals fed a Longevity Diet, as described in his book, lived longer. However, when moderate amounts of methionine, an amino acid, were included in the diet, frailty was avoided. He then analyzed a dataset of 200,000 health professionals in the United States and found that those consuming the highest amounts of animal protein had double the risk of type 2 diabetes, as well as higher rates of obesity and hypertension, compared with those consuming more plant protein. You can learn more about Dr. Longo's L-Protein powder (with methionine) at prolonlife.com/drkahn. Other topics include PCOS and heart disease, aortic dissection, artificial sweeteners and memory loss, optimal medical treatment for high cholesterol, GLP-1 agonist use and hair loss, TMAO and the risk of atrial fibrillation, statins and better cognitive function in women, and how plant mitochondria may improve our own cellular function. Amazing. Thanks to the Fresh Pressed Olive Oil Club. Learn more at getfreshDrKahn.com. Dr. Kahn's new book can be found here: amazon.com/dp/B0HBGJ4J59

  • July 24 · 27 min

    Episode 506: Advanced Cardiac Lab Testing With Dr. Ivan Rusilko

    In this bonus episode, Dr. Kahn interviews functional medicine specialist Ivan Rusilko about the importance of advanced lab panels. Together, they explore the full spectrum of cardiac lab testing, with a special focus on inflammation, insulin resistance, and how these markers can uncover hidden cardiovascular risk. If you are a health care practitioner, set up an account at accessmedlab.com. Mention the Heart Doc VIP Podcast when creating your new practitioner account to receive 50% off CardioPro™ Advanced Diagnostic Panels, providing unparalleled insights into patient health.

  • July 21 · 23 min

    Episode 505: A Breakthrough in Cholesterol Care With an Oral PCSK9 Inhibitor

    This week, Dr. Kahn discusses the FDA approval of the first oral PCSK9 inhibitor, Lipfendra (enclicitide), taken as a 20 mg daily tablet. In a study of nearly 3,000 patients with elevated LDL cholesterol despite treatment with statins and, in many cases, ezetimibe, LDL-C dropped by more than 50% while Lipoprotein(a) levels fell by 28%, with an excellent safety profile. The medication is expected to retail for approximately $315 per month and will be available in pharmacies soon. A larger outcomes trial evaluating its impact on heart attack and stroke rates is currently underway. Other topics include oatmeal for diabetes, avocados for cholesterol, ketogenic diets and cancer, serotonin and heart valve disease, air pollution and cardiovascular events, and the relationship between sweetened beverages, fruit juice, and high blood pressure. Dr. Kahn also mentions the air filtration system he uses at home and in his office, available at: airdoctorpro.com Finally, thanks to this week's sponsor, the Fresh Pressed Olive Oil Club. Learn more at getfreshDrKahn.com.

  • July 14 · 31 min

    Episode 504: Why Inflammation Matters for Patients with Lp(a)

    This week, Dr. Joel Kahn explores important new research showing how elevated inflammation, measured by Interleukin-6 (IL-6), may dramatically increase cardiovascular risk in people with high Lipoprotein(a), or Lp(a). He explains why IL-6 is emerging as an important biomarker and reviews the other inflammation tests he routinely uses at the Kahn Center, including hs-CRP, MPO, Lp-PLA2, NT-proBNP, fibrinogen, ferritin, the sedimentation rate, and the white blood cell count. Dr. Kahn also discusses Lilly's newly approved oral weight loss medication, the ABCDEF framework for cardiovascular prevention, the growing evidence linking erectile dysfunction and sleep apnea to heart disease, new research on cannabis use and coronary artery plaque, and intriguing early findings on creatine's potential role in supporting the immune system and anti-tumor activity. Finally, thanks to this week's sponsor, the Fresh Pressed Olive Oil Club. Visit getfreshDrKahn.com to take advantage of their special introductory offer and experience the health benefits of fresh, polyphenol-rich olive oil.

  • July 7 · 29 min

    Episode 503: Supplements to Reverse Atherosclerosis: Follow-Up to The Proof

    Dr. Joel Kahn explores the latest science on supplements that may help slow or reverse atherosclerosis, building on a recent discussion from Simon Hill's The Proof podcast. He takes a closer look at the evidence behind vitamin K2, niacin, pycnogenol with centella asiatica, beta-cyclodextrin, and bergamot, explaining where the research is strongest and what it could mean for heart health. Additional topics include new research on nutrient deficiencies to watch for in vegan diets, the potential kidney risks of certain calcium channel blockers, the health benefits of onions, advanced plaque measurements from coronary CT angiography, the connection between periodontal disease and kidney disease, and how fasting-mimicking diets may improve gum health. Dr. Kahn also reviews encouraging early results from an emerging Lipoprotein(a)-lowering therapy that could reduce the need for lipoprotein apheresis. Dr. Kahn is leading a group PROLON fasting-mimicking diet beginning this Sunday, July 12, and continuing for five days. A PROLON kit is required and can be purchased at prolonlife.com/drkahn. The NextGen version is recommended. Finally, a giant thanks to this week's sponsor, Igennus. Learn more at igennus.com/drkahn.

  • June 30 · 24 min

    Episode 502: Prozac (Fluoxetine) and Other Drugs That Injure Endothelium

    This week, Dr. Kahn reviews important new research showing that the commonly prescribed antidepressant Prozac (fluoxetine) may disrupt cholesterol metabolism, injure the endothelium (the delicate lining of arteries), and potentially increase cardiovascular risk. He also examines growing evidence linking proton pump inhibitors (PPIs) and several common cancer therapies to endothelial damage, emphasizing that patients should always discuss the risks and benefits of these medications with their healthcare team rather than stopping treatment on their own. Other topics include new Harvard research showing that combining aerobic exercise, strength training, and less time spent watching television can reduce the risk of type 2 diabetes by up to 60%; promising data on niacin for glioblastoma brain cancer; predicting statin-related muscle injury; the protective effects of plant-based diets against heart disease, dementia, and several cancers; tea consumption and lower cardiovascular risk; vitamin K-rich leafy greens and lung health; whole grains and breast cancer prevention; and the latest research on red meat, inflammatory bowel disease, and hypertension. Thanks to igennus.com/drkahn for this week's podcast sponsorship featuring their vegan Super B Complex.

  • June 23 · 27 min

    Episode 501: The Surprising Science of Gratitude and Heart Health

    Can a simple gratitude practice improve your heart health? This week, Dr. Kahn explores the growing science linking gratitude to better well-being, improved sleep, lower inflammation, and even enhanced cardiac function. He shares his own gratitude practices and offers practical ways to incorporate them into daily life. Also covered in this episode: how adherence to Life's Essential 8 is associated with longevity, even among the ultra-elderly; the importance of identifying cholesterol hyperabsorbers; the connection between obesity and cancer risk; the relationship between sleep apnea and Lipoprotein(a); why strength training is especially important for women; and the link between hypothyroidism and elevated homocysteine levels. Thanks to IGENNUS for their support of this episode, featuring their vegan Pro-Collagen Powder. Learn more at igennus.com/drkahn.

  • June 16 · 31 min

    Episode 500: The Long Path to Building an Integrative Cardiology Practice

    In this special 500th episode of Heart Doc VIP, Dr. Joel Kahn reflects on the personal and professional journey that shaped his 36-year career in cardiology and preventive medicine. From his childhood in Detroit and medical training at the University of Michigan to founding the Kahn Center for Cardiac Longevity, Dr. Kahn shares the mentors, experiences, and lessons that influenced his approach to patient care. He also reviews new research on heart disease mortality in the United States, vitamin K2 and coronary artery calcium progression, plant-based diets for chronic kidney disease, factors influencing carotid intima-media thickness (CIMT), and emerging advances in calcium scoring technology. Thank you to Igennus for sponsoring this milestone episode. Visit Igennus.com/DrKahn and use code DRKAHN for savings on their vegan-certified supplements.

  • June 9 · 29 min

    Episode 499: Why ApoB Could Be the Most Important Heart Health Test You're Missing

    In Episode 499, Dr. Joel Kahn explores the growing importance of apolipoprotein B (ApoB) testing as a powerful tool for assessing cardiovascular risk. He reviews new research highlighting why ApoB may provide a more complete picture of atherosclerosis risk than traditional cholesterol measurements alone and explains how it relates to LDL-C and Lp(a). Dr. Kahn also discusses several noteworthy studies in preventive medicine and longevity, including research linking GLP-1 medications to lower cancer risk, the potential DNA-protective effects of melatonin, and new findings on stroke and clot prevention in patients with atrial fibrillation. Additional topics include the relationship between very low Lp(a) levels and diabetes risk, the benefits of organic produce for breast cancer prevention, Pilates training for blood pressure management, and the connection between processed meat consumption and gastrointestinal cancers. The episode concludes with a look at Endothelin-1 (ET-1), an important marker involved in vascular health and cardiovascular disease, along with a discussion of Vinia grape powder and its potential role in lowering ET-1 levels. Thanks to Igennus.com and their Triple Vitamin K Complex using the discount code DrKahn

  • June 2 · 31 min

    Episode 498: Do You Want a One and Done Cholesterol Infusion? The Long Road Ahead

    Dr. Joel Kahn dives into a groundbreaking Phase 1 trial of Verve 102, a one-time intravenous gene-editing treatment that silences the PCSK9 gene to produce lasting LDL cholesterol reduction. Among 35 participants, the high-dose group saw LDL drop by 62% with mostly mild side effects — promising results, though Phase 2 and 3 trials and 15 years of follow-up still lie ahead. Also covered: updated colorectal cancer screening guidelines now starting at age 45, healthy lifestyle habits cutting mortality risk in cancer survivors by one-third, real-world weight regain data after stopping GLP-1 medications, why your B12 "normal" range may be too low, a blood test that may predict Alzheimer's years in advance, and a longevity preparedness tool from MIT AgeLab. Sponsored by Igennus — visit igennus.com/drkahn for 20% off.

  • May 26 · 29 min

    Episode 497: Retatrutide Delivers Stunning Weight Loss Results In Triumph-1 Study

    In this episode of HeartDoc VIP, Dr. Joel Kahn breaks down the newly released — but not yet fully published — results from the highly anticipated Triumph-1 study on retatrutide, an investigational weight loss medication that's already generating major buzz in the cardiometabolic world. The reported weight loss results at 80 and 104 weeks are remarkable, with side effects appearing consistent with other medications in this class, including semaglutide and tirzepatide. Dr. Kahn discusses what's known so far, what questions still remain, and why the full peer-reviewed publication is so important before drawing final conclusions on risks and benefits. FDA approval may not be far away. Other topics in this packed episode include the troubling rise in fatal heart attacks among younger adults, a modified Mediterranean diet linked to lower diabetes risk, the connection between food preservatives and heart disease, atrial fibrillation in athletes, nitric oxide's role in brain health, fatty liver disease and cardiovascular risk, and how the American Heart Association's Life's Essential 8 score may predict diabetes risk in women. Thanks to Igennus for sponsoring this episode. Visit their site and use promo code DRKAHN to save on high-quality supplements.

  • May 19 · 21 min

    Episode 496: 41 Lessons for Health and Longevity from Bryan Johnson

    This week, Dr. Kahn discusses Bryan Johnson's efforts to reverse his "biological age" and the 41 lessons he has shared along the way. These are valuable insights that Dr. Kahn largely endorses. Other topics include the sit-to-stand test; how PCOS can become PMOS; therapies for Peyronie's disease and PSA testing; plant-based diets and aging; plant-based diets during pregnancy; pregnancy complications; and the cardiac health of offspring. A big thanks to Igennus for supporting the podcast. Use discount code DrKahn to save on the BeKind line of plant-based nutritional products.

  • May 12 · 27 min

    Episode 495: New Research On Aged Garlic Extract, NAD+, And Heart Health

    This week, Joel Kahn, MD, dives into fascinating new research on aged garlic extract and its potential role in healthy aging, muscle function, and cardiovascular wellness. He reviews a recent study showing how aged garlic extract improved muscle and aging markers in mice while also activating the NAMPT pathway in humans, which may help boost NAD+ production. Dr. Kahn also breaks down several newer studies highlighting the cardiovascular benefits of aged garlic extract, a supplement he's used at the Kahn Center for more than a decade. He discusses the specific Kyolic formula available here: Kyolic Aged Garlic Extract Additional topics include dietary nitrates from greens and nitric oxide production, the Mediterranean diet and longevity, high-intensity interval training and heart health, visual acuity and lifespan, plant-based diets and breast cancer outcomes, and the connection between poor sleep and survival rates. This episode is brought to you by VINIA and their line of heart-supporting products.

Showing 1–20 of 24 episodes